Publications by authors named "Thomas Filleron"

100Publications

Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk.

Haematologica 2020 Jun 5;105(9):e480-483. Epub 2020 Jun 5.

Unit for Genomics in Myeloma, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse; Centre de Recherche en Cancérologie de Toulouse, Institut National de la Santé et de la Recherche Médicale U1037, Toulouse.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2019.236588DOI Listing
June 2020

Comparison of Variable Selection Methods for Time-to-Event Data in High-Dimensional Settings.

Comput Math Methods Med 2020 1;2020:6795392. Epub 2020 Jul 1.

Department of Biostatistics, Institut Claudius Regaud, IUCT-O, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2020/6795392DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350178PMC
July 2020

Modernizing adverse events analysis in oncology clinical trials using alternative approaches: rationale and design of the MOTIVATE trial.

Invest New Drugs 2020 Dec 7;38(6):1879-1887. Epub 2020 May 7.

Department of Biostatistics, Institut Claudius Regaud - IUCT-O, 1 avenue Irène Joliot-Curie, 31059, Toulouse Cedex 9, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-020-00938-xDOI Listing
December 2020

Low lean mass and chemotherapy toxicity risk in the elderly: the Fraction study protocol.

BMC Cancer 2019 Nov 27;19(1):1153. Epub 2019 Nov 27.

Geriatric Department, Internal Medicine and Oncogeriatry Unit, University Hospital, Place du Docteur Baylac, TSA 40031, 31059, Toulouse Cedex 9, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-019-6377-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882112PMC
November 2019

Anti-TNF, a magic bullet in cancer immunotherapy?

J Immunother Cancer 2019 11 14;7(1):303. Epub 2019 Nov 14.

INSERM UMR 1037, Cancer Research Center of Toulouse (CRCT), 2 avenue Hubert Curien, CS 53717, 31037, Toulouse Cedex 1, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-019-0802-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857159PMC
November 2019

Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemia.

BMC Cancer 2019 Aug 14;19(1):809. Epub 2019 Aug 14.

Department of Haematology, Toulouse-Oncopole University Cancer Institute (IUCT-O), 1 Avenue Irene Joliot-Curie, 31059, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-019-5971-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694602PMC
August 2019

Cutaneous Squamous Cell Carcinoma Tumour Size is Associated with Sentinel Lymph Node Metastasis in a Cohort of 69 Patients.

Acta Derm Venereol 2019 Dec;99(13):1241-1245

Department of ENT-Head and Neck Surgery, University Cancer Institute Toulouse and Toulouse University Hospital, Hôpital Larrey, FR-31400 Toulouse, France.

View Article

Download full-text PDF

Source
http://www.medicaljournals.se/acta/content/abstract/10.2340/
Publisher Site
http://dx.doi.org/10.2340/00015555-3293DOI Listing
December 2019

Gated F-FDG PET/CT of the Lung Using a Respiratory Spirometric Gating Device: A Feasibility Study.

J Nucl Med Technol 2019 Sep 24;47(3):227-232. Epub 2019 Apr 24.

Department of Nuclear Medicine, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France; and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnmt.118.223339DOI Listing
September 2019

Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas.

Mol Cancer Ther 2019 02 27;18(2):289-300. Epub 2018 Nov 27.

Université Fédérale de Toulouse Midi-Pyrénées, Université Toulouse III Paul-Sabatier, Inserm, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-17-1141DOI Listing
February 2019

Experimental study of pelvic perioperative brachytherapy with iodine 125 seeds (I-125) in an animal model.

J Contemp Brachytherapy 2018 Oct 31;10(5):463-469. Epub 2018 Oct 31.

Department of Radiotherapy, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopôle.

View Article

Download full-text PDF

Source
https://www.termedia.pl/doi/10.5114/jcb.2018.79470
Publisher Site
http://dx.doi.org/10.5114/jcb.2018.79470DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251451PMC
October 2018

Addressing heterogeneity in the design of phase II clinical trials in geriatric oncology.

Eur J Cancer 2018 11 14;103:120-126. Epub 2018 Sep 14.

Biostatistics Unit, Institut Claudius Regaud-IUCT-O, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2018.07.136DOI Listing
November 2018

Focus on an infrequently used quantity in the context of competing risks: The conditional probability function.

Comput Biol Med 2018 10 4;101:70-81. Epub 2018 Aug 4.

Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.compbiomed.2018.08.002DOI Listing
October 2018

New approach of ultra-focal brachytherapy for low- and intermediate-risk prostate cancer with custom-linked I-125 seeds: A feasibility study of optimal dose coverage.

Brachytherapy 2018 May - Jun;17(3):544-555. Epub 2018 Mar 7.

Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopôle, Department of Engineering and Medical Physics, Toulouse, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15384721183002
Publisher Site
http://dx.doi.org/10.1016/j.brachy.2018.01.011DOI Listing
February 2019

IDEAL 2a Phase II Study of Ultrafocal Brachytherapy for Low- and Intermediate-risk Prostate Cancer.

Int J Radiat Oncol Biol Phys 2018 11 2;102(4):903-911. Epub 2018 Feb 2.

Department of Urology, Institut Universitaire du Cancer de Toulouse, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2018.01.066DOI Listing
November 2018

Comparing sensitivity and specificity of medical imaging tests when verification bias is present: The concept of relative diagnostic accuracy.

Authors:
Thomas Filleron

Eur J Radiol 2018 Jan 31;98:32-35. Epub 2017 Oct 31.

Institut Claudius Regaud, IUCT-O 1 avenue Irène Joliot Curie, 31059 Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2017.10.022DOI Listing
January 2018

Continuous Infusion of Cilengitide Plus Chemoradiotherapy for Patients With Stage III Non-Small-cell Lung Cancer: A Phase I Study.

Clin Lung Cancer 2018 05 21;19(3):e277-e285. Epub 2017 Nov 21.

Department of Radiation Oncology, Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse, Oncopole, Toulouse, France; Université Paul Sabatier, Toulouse, France; INSERM U1037, Centre de Recherche Contre le Cancer de Toulouse, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.11.002DOI Listing
May 2018

[Nomograms in routine clinical practice: Methodology, interest and limitations].

Bull Cancer 2018 Jan 6;105(1):15-24. Epub 2017 Dec 6.

Institut Claudius-Regaud, IUCT-oncopole, département de chirurgie, 1, avenue Irène-Joliot-Curie, 31059 Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2017.10.024DOI Listing
January 2018

Comparison of variable selection methods for high-dimensional survival data with competing events.

Comput Biol Med 2017 12 20;91:159-167. Epub 2017 Oct 20.

Department of Biostatistics, Institut Claudius Regaud, IUCT-O, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.compbiomed.2017.10.021DOI Listing
December 2017

Impact of surgery on survival in stage IV breast cancer.

Breast J 2017 11 15;23(6):774. Epub 2017 May 15.

Medical Oncology, IUCT-Oncopole, Institut Claudius Regaud, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.12822DOI Listing
November 2017

Methodology of phase II clinical trials in metastatic elderly breast cancer: a literature review.

Breast Cancer Res Treat 2017 Aug 9;164(3):505-513. Epub 2017 May 9.

Biostatistics Unit, Bureau des Essais Cliniques, Institut Claudius Regaud-IUCT-Oncopole, 1 avenue Irène Joliot Curie, 31059, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4278-5DOI Listing
August 2017

Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network.

J Clin Oncol 2017 Jun 1;35(18):2008-2017. Epub 2017 May 1.

Camille Laurent, Nadia Amara, Georges Delsol, and Pierre Brousset, Institut Universitaire du Cancer-Oncopole de Toulouse; Centre Hospitalier Universitaire (CHU) Toulouse; Camille Laurent, Georges Delsol, and Pierre Brousset, Institut National de la Santé et de la Recherche Médicale (INSERM), U.1037, Centre de Recherche en Cancerologie de Toulouse-Purpan, Laboratoire d'Excellence Toulouse Cancer; Thomas Filleron, Institut Claudius Regaud, L'Institut Universitaire du Cancer de Toulouse, Toulouse; Marine Baron, Corinne Haioun, Christiane Copie-Bergman, and Philippe Gaulard, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Henri Mondor-Albert Chenevier; Corinne Haioun, Christiane Copie-Bergman, and Philippe Gaulard, INSERM U955, Université Paris-Est, Créteil; Mylène Dandoit, Marc Maynadié, and Laurent Martin, CHU de Dijon, Dijon; Marie Parrens, Beatrice Vergier, and Antoine de Mascarel, Hôpital du Haut Lévêque, CHU de Bordeaux, Bordeaux; Bettina Fabiani, AP-HP, Hôpital Saint-Antoine; Nicole Brousse and Thierry Jo Molina, AP-HP, Hôpital Necker; Josette Brière, AP-HP, Hôpital Saint Louis; Fréderic Charlotte, AP-HP, Hôpital Pitié Salpétrière; Diane Damotte, AP-HP, Hôpitaux Universitaires Paris Centre, Paris; Alexandra Traverse-Glehen and Françoise Berger, CHU Lyon-Sud; Catherine Chassagne-Clement, Centre Léon Bérard, Lyon; Marie-Christine Copin, Univ Lille, CHU Lille, Lille; Patrick Tas, CHU de Rennes, Rennes; Marie-Christine Rousselet, CHU d'Angers, Angers; Thérèse Rousset, Hôpital Gui de Chauliac, CHU de Montpellier, Montpellier; Luc Xerri, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille; Anne Moreau and Céline Bossard, Hôpital Hôtel Dieu, CHU de Nantes, Nantes; Antoine Martin, Hôpital Avicenne, Bobigny, Bobigny; Peggy Dartigues, Institut Gustave Roussy, Villejuif; Isabelle Soubeyran, Institut Bergonié, Bordeaux; Michel Peoch, CHU de Saint Etienne, Saint Etienne; Pierre Dechelotte, CHU de Clermont-Ferrand, Clermont-Ferrand; Jean-François Michiels, CHU de Nice, Nice; Flavie Arbion, CHU de Tours, Tours; Isabelle Quintin-Roué, CHU de Brest, Brest; Jean-Michel Picquenot, Centre Henri Becquerel, CHU de Rouen, Rouen; Martine Patey, CHU de Reims, Reims; Blandine Fabre, CHU de Grenoble, Grenoble; Henri Sevestre, CHU d'Amiens, Amiens; Cécile Le Naoures, CHU de Caen, Caen; Marie-Pierre Chenard-Neu, CHU de Strasbourg, Strasbourg; Claire Bastien, CHU de Nancy, Nancy; Sylvie Thiebault, CH de Mulhouse, Mulhouse; Manuela Delage, CHU de Limoges, Limoges; Gilles Salles, Hospices Civils de Lyon, CHU Lyon-Sud; Gilles Salles, INSERM1052, Centre National de la Recherche Scientifique 5286, Université Claude Bernard, Pierre Bénite, France; Tony Petrella, Pathology University of Montréal, Hôpital Maisonneuve-Rosemont, Montréal, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.2083DOI Listing
June 2017

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.

J Clin Oncol 2017 May 13;35(13):1403-1410. Epub 2017 Mar 13.

Oliver Gautschi, Kristin Zeidler, and Joachim Diebold, Lucerne Cantonal Hospital, Luzern; Patrizia Froesch, Ente Ospedaliero Cantonale, Bellinzona; Martin Früh, Kantonsspital St Gallen, St Gallen; Sacha I. Rothschild, University Hospital Basel, Basel, Switzerland; Julie Milia and Julien Mazières, Hôpital Larrey; Thomas Filleron, Institut Universitaire du Cancer, Claudius Regaud, Toulouse; Benjamin Besse and Jordi Remon-Masip, Institute Gustave Roussy, Villejuif; Gérard Zalcman, University Hospital Bichat, Paris; Isabelle Monnet, Centre Hospitalier Intercommunal de Creteil, Creteil; Florian Cabillic, Université de Rennes 1, Rennes, France; Juergen Wolf and Sebastian Michels, Center for Integrated Oncology, Cologne; Georg Pall, Fachkliniken Wangen, Wangen Im Allgäu; Arne Warth, Heidelberg University Hospital; Thomas Muley, Thoraxklinik at University of Heidelberg and Translational Lung Research Center, Heidelberg, Germany; David P. Carbone and Dwight Owen, Ohio State University Comprehensive Cancer Center, Columbus; Vamsidhar Velcheti, Cleveland Clinic, Pepper Pike, OH; Ross Camidge and Vignhesh Narayanan, University of Colorado, Denver; Robert C. Doebele, University of Colorado, Aurora, CO; Pasi A. Janne and Mark M. Awad, Dana-Farber Cancer Institute, Boston, MA; Daniel D. Karp, The University of Texas MD Anderson Cancer Center, Houston, TX; Heather A. Wakelee and Joel W. Neal, Stanford University, Stanford; Sai-Hong Ignatius Ou, University of California, Irvine, Orange; David R. Gandara and Jonathan W. Riess, University of California, Davis Cancer Center, Sacramento, CA; Alexander Drilon, Memorial Sloan Kettering Cancer Center, New York, NY; Nir Peled, Davidoff Cancer Center, Petach Tiqwa, Israël; Chul-Cho Byoung, Yonseï Cancer Center, Seoul, Republic of Korea; Michael Van Den Heuvel, Netherlands Cancer Institute, Amsterdam, the Netherlands; Tony S.K. Mok, The Chinese University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China; James C.H. Yang and Jin-Yuan Shih, National Taiwan University Hospital, Taipei, Republic of China; Sanjay Popat, Royal Marsden Hospital, London, United Kingdom; and Rafael Rosell and Niki Karachaliou, Catalan Institute of Oncology, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.9352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559893PMC
May 2017

External validation of a published nomogram for prediction of brain metastasis in patients with extra-cerebral metastatic breast cancer and risk regression analysis.

Eur J Cancer 2017 02 30;72:200-209. Epub 2016 Dec 30.

Department of Medical Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.10.019DOI Listing
February 2017

[Subgroup analysis and forest plots: Limitations and interests].

Bull Cancer 2017 Jan 4;104(1):92-100. Epub 2016 Nov 4.

Institut Claudius-Regaud, IUCT-oncopole, bureau des essais cliniques, 1, avenue Irène-Joliot-Curie, 31059 Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.09.023DOI Listing
January 2017

Goodness-of-fit test for monotone proportional subdistribution hazards assumptions based on weighted residuals.

Stat Med 2017 01 28;36(2):362-377. Epub 2016 Oct 28.

Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, ON N2L 3G1, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/sim.7153
Publisher Site
http://dx.doi.org/10.1002/sim.7153DOI Listing
January 2017

A Statistical Approach to Determine the Optimal Duration of Post-Treatment Follow-Up: Application to Metastatic Nonseminomatous Germ Cell Tumors.

Clin Genitourin Cancer 2017 04 8;15(2):230-236. Epub 2016 Aug 8.

Bureau des Essais Cliniques, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse - Oncopole, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2016.07.023DOI Listing
April 2017

[Erratum to "Propensity score: A credible alternative to randomization?" [Bull. Cancer 103 (2014) 113-22]].

Bull Cancer 2016 Jul-Aug;103(7-8):706. Epub 2016 Jun 23.

CLCC Jean-Perrin, 58, rue Montalembert, 63011 Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.05.008DOI Listing
June 2016

Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: Results of the OXYTAM study.

J Steroid Biochem Mol Biol 2017 05 22;169:210-218. Epub 2016 Jun 22.

Inserm UMR 1037, Team "Cholesterol metabolism and therapeutic innovations", Cancer Research Center of Toulouse, Toulouse, France; University of Toulouse III, Toulouse France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jsbmb.2016.06.010DOI Listing
May 2017

Outcome of pN0 Triple-Negative Breast Cancer with or without Lymph Node Irradiation: A Single Institution Experience.

Breast J 2016 Sep 4;22(5):510-9. Epub 2016 Jun 4.

Department of Radiation Oncology, Institut Claudius Regaud / Institut Universitaire du Cancer de Toulouse - Oncopôle, Toulouse, Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.12626DOI Listing
September 2016

Malignant Peripheral Nerve Sheath Tumor Is a Challenging Diagnosis: A Systematic Pathology Review, Immunohistochemistry, and Molecular Analysis in 160 Patients From the French Sarcoma Group Database.

Am J Surg Pathol 2016 07;40(7):896-908

Departments of *Pathology ‡Biostatistics **Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse †Department of Pathology, Centre Léon Bérard, Lyon §Department of Pathology, Centre Paul Papin, Angers ∥Department of Pathology, Centre Georges-Francois Leclerc, Dijon ¶Department of Pathology, Centre Oscar Lambret, Lille #Department of Pathology, Institut Gustave Roussy, Villejuif ††Department of Pathology and INSERM U916, Institut Bergonié ‡‡University Bordeaux Ségalen, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000655DOI Listing
July 2016

PERK mediates the IRES-dependent translational activation of mRNAs encoding angiogenic growth factors after ischemic stress.

Sci Signal 2016 05 3;9(426):ra44. Epub 2016 May 3.

INSERM, UMR 1037, CRCT (Cancer Research Center of Toulouse), F-31037 Toulouse, France. Université Toulouse III Paul Sabatier, F-31000 Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scisignal.aaf2753DOI Listing
May 2016

Characteristics and Clinical Outcomes of Sarcomatoid Carcinoma of the Lung.

Clin Lung Cancer 2016 09 17;17(5):391-397. Epub 2016 Mar 17.

Pulmonary Medicine Unit, Hôpital Larrey, Centre Hospitalier Universitaire Toulouse, Université de Toulouse III, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.03.001DOI Listing
September 2016

Oncologic surveillance after curative treatment: A probability-based approach should be preferred to a risk-based approach.

Urol Oncol 2016 May 30;34(5):244-5. Epub 2016 Mar 30.

Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse-Oncopole, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10781439160008
Publisher Site
http://dx.doi.org/10.1016/j.urolonc.2016.02.026DOI Listing
May 2016

[Propensity score: A credible alternative to randomization?].

Bull Cancer 2016 Jan 3;103(1):113-22. Epub 2015 Dec 3.

CLCC Jean-Perrin, 58, rue Montalembert, 63011 Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2015.10.012DOI Listing
January 2016

Analysis of survival adjusted for quality of life using the Q-TWiST function: Interface in R.

Comput Methods Programs Biomed 2016 Mar 19;125:79-87. Epub 2015 Nov 19.

Methodology and Biostatistics Unit, Centre Oscar Lambret, Lille and SIRIC ONCOLille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cmpb.2015.11.005DOI Listing
March 2016

A Systematic Review and Meta-Analysis of Double Venous Anastomosis in Free Flaps.

Plast Reconstr Surg 2015 Dec;136(6):1299-311

Toulouse, Montpellier, Lyon, and Rennes, France From the Department of Plastic and Reconstructive Surgery, Rangueil University Hospital; the Departments of Plastic and Reconstructive Surgery and Biostatistics and Medical Information, Lapeyronie University Hospital; the Department of Plastic and Reconstructive Surgery, Edouard Herriot University Hospital; the Department of Plastic, Reconstructive, and Aesthetic Surgery, Hospital Sud, University of Rennes 1; and the Biostatistic Unit, Institut Universitaire du Cancer Toulouse.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PRS.0000000000001791DOI Listing
December 2015

What to expect from molecular tools for non-documented pediatric infectious diseases.

Expert Rev Mol Diagn 2015 27;15(12):1645-56. Epub 2015 Oct 27.

c UMR HydroSciences Montpellier, Equipe Pathogènes Hydriques Santé Environnements, U.F.R. des Sciences Pharmaceutiques et Biologiques , Université Montpellier 1 , Montpellier Cedex 5 , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737159.2015.1105132DOI Listing
September 2016

Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort.

J Thorac Oncol 2015 Oct;10(10):1451-7

*Tumorzentrum, Luzerner Kantonsspital, Luzern, Switzerland; †Hôpital Larrey, Centre Hospital-Universitaire, Université Paul Sabatier, Toulouse, France; ‡Institut Claudius Regaud IUCT-O, Toulouse, France; §Institut Gustave Roussy, Villejuif, France; ¶VU University Medical Center, Amsterdam, The Netherlands; ‖Center of Integrated Oncology Cologne, University Hospital Cologne, Cologne, Germany; #Centre Pluridisciplinaire d'Oncologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; **Onkologie/Hämatologie, Kantonsspital St. Gallen, St. Gallen, Switzerland; ††Medizinische Klinik, St. Claraspital, Basel, Switzerland; ‡‡Service de pneumologie et oncologie thoracique, Hopital Universitaire, Caen, France; §§University Hospital Essen, Essen, Germany; ¶¶University Hospital Zurich, Zurich, Switzerland; ‖‖Clinique Teissier, Valenciennes, France; ##Centre Hospitalier Intercommunal de Creteil, Créteil, France; ***University Hospital Innsbruck, Innsbruck, Austria; †††University Hospital Basel, Basel, Switzerland; ‡‡‡Heidelberg University Medical Center, Mannheim, Germany; §§§Hopital du Haut Lévèque, Pessac, France; ¶¶¶Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; and ‖‖‖Centre Hospitalier Universitaire, Université de Caen-Basse Normandie, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000625DOI Listing
October 2015

Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I-II trial of radiotherapy/tipifarnib combination.

J Neurooncol 2015 Sep 19;124(3):465-73. Epub 2015 Jul 19.

Department of Radiotherapy, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopôle, 1, avenue Irene Joliot-Curie, 31059, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-015-1860-8DOI Listing
September 2015

Prediction of early breast cancer metastasis from DNA microarray data using high-dimensional cox regression models.

Cancer Inform 2015 5;14(Suppl 2):129-38. Epub 2015 May 5.

Département de la Recherche Clinique et de l'Innovation, Unité de Biostatistique et de Méthodologie, Institut Paoli-Calmettes, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CIN.S17284DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426954PMC
May 2015

Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort.

J Clin Oncol 2015 Mar 9;33(9):992-9. Epub 2015 Feb 9.

Julien Mazières, Damien Rouvière, and Julie D. Milia, Hôpital Larrey, Centre Hospitalier Universitaire, Université Paul Sabatier; Thomas Filleron, Institut Universitaire du Cancer, Toulouse; Gérard Zalcman, Centre Hospitalier Universitaire, Université de Caen-Basse Normandie, Caen; Pamela Biondani and Benjamin Besse, Gustave Roussy, Villejuif; Fabrice Barlesi, Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Marseille; Hervé Léna, Centre Hospitalier Universitaire, Rennes; Isabelle Monnet, Centre Hospitalier Intercommunal de Créteil, Créteil; Luc Thiberville, Centre Hospitalier Universitaire, Rouen; Nicolas Pecuchet, Institut Curie, Paris, France; Lucio Crinò, Medica-Azienda Ospedaliera, Perugia; Federico Cappuzzo, Istituto Toscano Tumori, Ospedale Civile, Livorno, Italy; Anne-Marie C. Dingemans, Maastricht University Medical Center, Maastricht; Egbert F. Smit, VU University Medical Center, Amsterdam, the Netherlands; Sacha I. Rothschild, University Hospital Basel, Medical Oncology, Basel; Christian Spirig, Klinik St Anna; Joachim Diebold and Oliver Gautschi, Cantonal Hospital Luzern, Lucerne, Switzerland; Rafal Dziadziuszko, Gdansk Medical University, Gdansk, Poland; Jurgen Wolf and Roman K. Thomas, Center of Integrated Oncology Köln-Bonn, University Hospital Cologne, University of Cologne; Frauke Leenders and Roman K. Thomas, University of Cologne; Johannes M. Heuckmann, Blackfield AG, Cologne, Germany.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/02/03/JCO.2014.58
Web Search
http://jco.ascopubs.org/content/early/2015/02/03/JCO.2014.58
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.58.3302
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.58.3302DOI Listing
March 2015

Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma.

Oncologist 2015 Jan 26;20(1):62-71. Epub 2014 Dec 26.

Clinical Research and Innovation Directorate, Amiens University Hospital, Amiens, France; Methodology and Quality of Life in Oncology Unit, EA 3181 CHU Besançon and the Qualité de Vie et Cancer Clinical Research Platform, Dijon, France; Fédération Française de Cancérologie Digestive (French Society for Digestive Oncology), Dijon, France; Department of Hepatogastroenterology, Reims University Hospital, Reims, France; Department of Hepatogastroenterology and Digestive Oncology, La Timone University Hospital, Marseille, France; Biostatistics Service, Curie Institute, Paris, France; Biostatistics Unit, Claudius Régaud Institute, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0175DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294602PMC
January 2015

Perception of lung cancer among the general population and comparison with other cancers.

J Thorac Oncol 2015 Mar;10(3):420-5

*Thoracic Oncology Department, Larrey Hospital, University Hospital of Toulouse, University of Toulouse III (Paul Sabatier), Toulouse, France; †Thoracic Oncology Unit; and ‡Epsylon Laboratory, Montpellier Academic Hospital, Montpellier, France; §Social Psychology Research Group (EA 4163), University Lyon 2, France; ‖Pulmonary Department, Avicenne Hospital, Bobigny, France; ¶Pulmonary Department, University Hospital of Strasbourg, France; #Statistic Department, Institut Universitaire du Cancer, Toulouse, France; **General Practitioner Clinic, Levallois Perret, France; ††Interdisciplinary Institute for Contemporary Anthropology, UMR 8177 CNRS/EHESS, Ehess, France; ‡‡Hopital Tenon APHP, Paris, France; and §§Intergroupe Francophone de Cancérologie Thoracique, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000433DOI Listing
March 2015

Dosimetric comparison between helical tomotherapy and volumetric modulated arc-therapy for non-anaplastic thyroid cancer treatment.

Radiat Oncol 2014 Nov 26;9:247. Epub 2014 Nov 26.

Department of Radiation Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, Oncopôle - 1, avenue Irène Joliot Curie, 31059, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13014-014-0247-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251932PMC
November 2014

Measurement of inter- and intra-observer variability in the routine clinical interpretation of brain 18-FDG PET-CT.

Ann Nucl Med 2015 Apr 22;29(3):233-9. Epub 2014 Nov 22.

Department of Radiology, Toulouse University Hospital, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12149-014-0932-8DOI Listing
April 2015

Long-term oncological outcome after endoscopic surgery for olfactory esthesioneuroblastoma.

Acta Otolaryngol 2014 Dec;134(12):1259-64

Otolaryngology, Head and Neck Surgery Department, University Hospital Rangueil-Larrey , Toulouse , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00016489.2014.944271DOI Listing
December 2014

Intensity-modulated radiotherapy for laryngeal and hypopharyngeal cancer: minimization of late dysphagia without jeopardizing tumor control.

Strahlenther Onkol 2015 Mar 1;191(3):225-33. Epub 2014 Nov 1.

Department of Radiation Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer, 1 avenue Irène Joliot-Curie, 31059, Toulouse, Cedex 9, France,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00066-014-0767-1
Publisher Site
http://dx.doi.org/10.1007/s00066-014-0767-1DOI Listing
March 2015

Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.

Int J Radiat Oncol Biol Phys 2014 Oct 4;90(2):385-93. Epub 2014 Aug 4.

Département de Radiothérapie, Institut Claudius Regaud, Toulouse, France; UMR (Unité Mixte de Recherche) 825, Institut National de la Santé et de la Recherche Médicale, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2014.06.009DOI Listing
October 2014

Optimal scheduling of post-therapeutic follow-up of patients treated for cancer for early detection of relapses.

Stat Methods Med Res 2016 12 24;25(6):2457-2471. Epub 2014 Feb 24.

Cellule de Biostatistique, Institut Claudius Regaud, Toulouse, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0962280214524178DOI Listing
December 2016

Prognostic relevance of celiac lymph node involvement in ovarian cancer.

Int J Gynecol Cancer 2014 Jan;24(1):48-53

*Department of Surgical Oncology, Claudius Regaud Comprehensive Cancer Center; †Department of Surgical Oncology, Jean Perrin Comprehensive Cancer Center, Clermont-Ferrand, France; Departments of ‡Biostatistics, §Pathology, and ∥Medical Oncology, Claudius Regaud Comprehensive Cancer Center, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000041DOI Listing
January 2014

Recurrence risk after Ivor Lewis oesophagectomy for cancer.

J Cardiothorac Surg 2013 Nov 21;8:215. Epub 2013 Nov 21.

Department of Digestive Surgery, Toulouse Purpan University Hospital, Toulouse III University, place du Dr Baylac, 31059 Toulouse France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1749-8090-8-215DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892033PMC
November 2013